These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 6086213

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Antibiotic susceptibility profile of Xanthomonas maltophilia. In vitro activity of beta-lactam/beta-lactamase inhibitor combinations.
    García-Rodríguez JA, García Sánchez JE, García García MI, García Sánchez E, Muñoz Bellido JL.
    Diagn Microbiol Infect Dis; 1991; 14(3):239-43. PubMed ID: 1889176
    [Abstract] [Full Text] [Related]

  • 23. Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with ampicillin and broad-spectrum penicillins against defined beta-lactamase-producing aerobic gram-negative bacilli.
    Jacobs MR, Aronoff SC, Johenning S, Shlaes DM, Yamabe S.
    Antimicrob Agents Chemother; 1986 Jun; 29(6):980-5. PubMed ID: 3015017
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Activity of cefazolin and two beta-lactamase inhibitors, clavulanic acid and sulbactam, against Bacteroides fragilis.
    Fekete T, McGowen J, Cundy KR.
    Antimicrob Agents Chemother; 1987 Feb; 31(2):321-2. PubMed ID: 3032097
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. beta-Lactamase inhibition and in vitro activity of sulbactam and sulbactam/cefoperazone.
    Williams JD.
    Clin Infect Dis; 1997 Mar; 24(3):494-7. PubMed ID: 9114205
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Beta-lactamase inhibition by acetylmethylene penicillanic acid compared to that of clavulanate and sulbactam.
    Chin NX, McElrath MJ, Neu HC.
    Chemotherapy; 1988 Mar; 34(4):318-25. PubMed ID: 2850139
    [Abstract] [Full Text] [Related]

  • 35. Characterization of a beta-lactamase produced by Pseudomonas paucimobilis.
    Corkill JE, Hart CA, McLennan AG, Aspinall S.
    J Gen Microbiol; 1991 Jun; 137(6):1425-9. PubMed ID: 1655952
    [Abstract] [Full Text] [Related]

  • 36. In vitro activity of cefodizime (HR-221) in combination with beta-lactamase inhibitors.
    Segatore B, Perilli M, Franceschini N, Setacci D, Oratore A, Amicosante G.
    J Chemother; 1993 Jun; 5(3):147-50. PubMed ID: 8396624
    [Abstract] [Full Text] [Related]

  • 37. [The effectiveness of so-called potentiated penicillins (augmentin and tazobactam) in vitro].
    Blahová J, Hupková M, Krcméry V.
    Cas Lek Cesk; 1995 Sep 06; 134(17):558-61. PubMed ID: 7553760
    [Abstract] [Full Text] [Related]

  • 38. [Sulbactam and clavulanic acid: studies of enzyme kinetics and synergism with ampicillin and mezlocillin].
    Cullmann W, Binder S, Stieglitz M.
    Immun Infekt; 1987 May 06; 15(3):103-9. PubMed ID: 3038733
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. In vitro activities of piperacillin or cefoperazone alone and in combination with beta-lactamase inhibitors against gram-negative bacilli.
    Kuo HY, Wang FD, Yen YF, Lin ML, Liu CY.
    New Microbiol; 2009 Jan 06; 32(1):49-55. PubMed ID: 19382669
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.